What happened
Aonong Bio (603363.SH) announced on September 1 that it had received an advance notice of administrative penalties from the Fujian bureau of the China Securities Regulatory Commission, proposing a 2.5 million yuan fine for the company and a combined 3.15 million yuan for four individuals, including former chairman and general manager Wu Youlin and deputy general manager and board secretary Peng Jiang.
The notice said the company failed to disclose 207 new lawsuits and arbitrations between June 2024 and February 2025, involving a total of 907 million yuan. It also failed to disclose related-party transactions totaling 160 million yuan from January 1 to March 26, 2025, which accounted for 31.89% of the company's latest audited net assets, with only partial disclosure made on March 28.
Separately on the same day, the company said Peng Jiang had resigned as board secretary due to a work change, effective September 1. He will remain deputy general manager and general manager of the feed division.
Why it matters
The proposed penalties highlight regulators' increasing focus on timely disclosure of material litigation and related-party transactions, which can significantly affect investor judgment and market transparency.
Although the company says the issues will not materially affect its production, finances, or normal operations, the large number and value of undisclosed matters may raise concerns about internal governance and compliance controls.
The company's acknowledgement of violations and admission of fault reportedly led to lighter punishment, but the final outcome still depends on the regulatory process.
Key facts
The Fujian bureau proposed fining Aonong Bio 2.5 million yuan and four individuals a combined 3.15 million yuan.
From June 2024 to February 2025, 207 lawsuits and arbitrations totaling 907 million yuan were not disclosed in a timely manner.
Related-party transactions of 160 million yuan, equal to 31.89% of audited net assets, were only partially disclosed on March 28, 2025.
Peng Jiang resigned as board secretary on September 1 but continues as deputy general manager and feed division general manager.
What to watch next
Whether the proposed fines become final after the company's response and the regulator's final decision.
How Aonong Bio strengthens its disclosure practices, given its assertion that operations remain normal and orderly.
Whether any additional regulatory or exchange measures follow, particularly regarding the previously undisclosed litigation and related-party transactions.